Dr. Lugogo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
380 Parkland Plaza
Ann Arbor, MI 48103Phone+1 734-998-7380
Clinical Expertise
- Refractory asthma
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2001 - 2004
Virginia Commonwealth University School of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2017 - 2027
NC State Medical License 2001 - 2018
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellows Teaching Award Pulmonary Division, University of Michigan, 2019
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
- PackHealth: Asthma Engagement Tool Start of enrollment: 2015 Aug 01
- Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- 1 citationsEffect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, plac...Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira L Lugogo, Christopher E Brightling
The Lancet. Respiratory Medicine. 2025-02-10 - International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update.Désirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, John Busby, Trung N Tran
Tuberculosis and Respiratory Diseases. 2025-02-06 - Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.Njira L Lugogo, Xavier Soler, Yasuhiro Gon, Andréanne Côté, Ole Hilberg
Advances in Therapy. 2025-02-01
Press Mentions
NAVIGATOR Steers Uncontrolled Asthma Toward Calmer SeasMay 18th, 2022- NAVIGATOR: Nearly Half of Patients with Severe, Uncontrolled Asthma Improved with TezepelumabMay 17th, 2022
- When All Else Failed, Biologics Helped Her Breathe AgainFebruary 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
